Profile data is unavailable for this security.
About the company
PT Tempo Scan Pacific Tbk is an Indonesia-based company primarily engaged in pharmaceutical industry. The Company’s business divisions include Pharmaceutical division, Consumer Products and Cosmetics division, Manufacturing division, and Distribution division. Its Pharmaceutical division manufactures and markets various over-the-counter (OTC) and ethical drugs, as well as consumer health care products. Its Consumer Products and Cosmetics Division markets and distributes consumer products, as well as licensed cosmetics products, such as hand sanitizer, anti-germs soap, antiseptic liquid, antibacterial wipes, surgical mask and household products. Its Manufacturing division consists of 10 companies that operates approximately 17 manufacturing facilities located across Bekasi, West Java and Mojokerto, East Java. Its Distribution division distributes Company’s products to customers, as well as third-party products. Its business network cover 219 locations that consist of 46 branches.
- Revenue in IDR (TTM)11.98tn
- Net income in IDR818.70bn
- Incorporated1971
- Employees4.55k
- LocationTempo Scan Pacific Tbk PTLantai 16, Tempo Scan TowerJl. HR. Rasuna Said Kav. 3-4JAKARTA 12950IndonesiaIDN
- Phone+62 2 921888854
- Fax+62 29209999
- Websitehttps://www.temposcangroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indofarma Tbk PT | 2.31tn | -223.52bn | 2.11tn | 1.18k | -- | 6.48 | -- | 0.9127 | -72.15 | -72.15 | 745.51 | 104.92 | 1.11 | 6.05 | 5.69 | 1,842,803,000.00 | -10.77 | -1.40 | -23.64 | -2.79 | 1.35 | 17.81 | -9.68 | -1.18 | 0.9242 | -3.14 | 0.5993 | -- | 69.15 | 11.62 | -136,356.00 | -- | -18.53 | -- |
| Merck Tbk PT | 1.15tn | 163.62bn | 2.17tn | 393.00 | 13.25 | 2.99 | 11.41 | 1.89 | 365.22 | 365.22 | 2,561.49 | 1,621.14 | 1.22 | 2.16 | 8.41 | 2,980,644,000.00 | 17.45 | 7.22 | 21.69 | 10.91 | 37.78 | 39.04 | 14.26 | 9.53 | 1.92 | 34.45 | 0.0235 | 426.22 | 62.29 | 0.5654 | 83.11 | -3.07 | 11.07 | -2.69 |
| Darya-Varia Laboratoria Tbk PT | 1.86tn | 43.95bn | 2.21tn | 1.26k | 50.32 | 1.52 | 20.61 | 1.19 | 39.25 | 39.25 | 1,657.99 | 1,300.03 | 0.8719 | 2.22 | 2.66 | 1,498,745,000.00 | 2.06 | 9.98 | 2.72 | 13.52 | 52.33 | 53.53 | 2.37 | 10.13 | 2.18 | -- | 0.0018 | 67.95 | 3.89 | 5.54 | -9.47 | -0.7147 | -14.99 | 11.89 |
| Kimia Farma Tbk PT | 10.50tn | -180.60bn | 5.09tn | 11.51k | -- | 0.705 | 19.42 | 0.4848 | -32.52 | -32.52 | 1,890.12 | 1,297.92 | 0.5598 | 2.19 | 4.54 | 881,718,000.00 | -1.01 | 1.82 | -1.64 | 3.00 | 33.85 | 36.28 | -1.80 | 2.55 | 0.5965 | 0.5404 | 0.5492 | 24.79 | 28.50 | 17.21 | 1,613.68 | 2.48 | 12.14 | 11.14 |
| Tempo Scan Pacific Tbk PT | 11.98tn | 818.70bn | 6.27tn | 4.55k | 7.60 | 0.9163 | 5.49 | 0.5233 | 183.00 | 183.00 | 2,679.31 | 1,516.93 | 1.18 | 4.34 | 9.26 | 2,535,298,000.00 | 8.48 | 8.33 | 11.51 | 11.46 | 34.26 | 37.20 | 7.16 | 6.44 | 1.85 | -- | 0.1604 | 36.32 | 2.43 | 4.22 | 4.57 | 8.96 | -0.1237 | 6.96 |
| Soho Global Health Tbk PT | 6.89tn | 325.04bn | 6.60tn | 2.41k | 20.30 | 2.65 | 16.78 | 0.9574 | 256.10 | 256.10 | 5,431.66 | 1,963.83 | 1.52 | 4.70 | 4.87 | 2,875,966,000.00 | 7.15 | -- | 12.94 | -- | 18.72 | -- | 4.72 | -- | 1.46 | -- | 0.0108 | -- | 14.80 | -- | 219.67 | -- | -- | -- |
| PT Industri Jamu dan Farmasi Sd Mncl Tbk | 3.87tn | 1.10tn | 25.95tn | 3.17k | 23.47 | 7.40 | 21.41 | 6.71 | 36.85 | 36.85 | 128.85 | 116.85 | 0.9486 | 3.41 | 5.72 | 1,220,948,000.00 | 27.11 | 25.92 | 31.27 | 29.54 | 55.95 | 55.08 | 28.58 | 27.98 | 3.05 | -- | 0.0007 | -- | -3.87 | 8.47 | -12.39 | 15.66 | -12.18 | -- |
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Singapore) Ltd.as of 31 Jan 2023 | 97.19m | 2.16% |
| Fidelity Management & Research Co. LLCas of 31 Jan 2023 | 24.98m | 0.55% |
| Fidelity Investments Canada ULCas of 31 Jan 2023 | 10.00m | 0.22% |
| Samarang LLPas of 30 Jun 2022 | 8.00m | 0.18% |
| Dimensional Fund Advisors LPas of 02 Mar 2023 | 7.55m | 0.17% |
| Niche Asset Management Ltd.as of 30 Sep 2021 | 2.20m | 0.05% |
| PT Manulife Aset Manajemen Indonesiaas of 31 Dec 2019 | 1.16m | 0.03% |
| Pheim Asset Management Sdn. Bhd.as of 22 Nov 2021 | 765.30k | 0.02% |
| FIL Investment Advisors (UK) Ltd.as of 30 Nov 2022 | 636.50k | 0.01% |
| Segall Bryant & Hamill LLCas of 28 Feb 2023 | 612.00k | 0.01% |
